In Silico Drug Design and Analysis of Dual Amyloid-Beta and Tau Protein-Aggregation Inhibitors for Alzheimer’s Disease Treatment
Author:
Affiliation:
1. Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India
2. Department of Chemistry and Biochemistry, San Diego State University, San Diego, CA 92182, USA
Abstract
Funder
VIT SEED
Publisher
MDPI AG
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Link
https://www.mdpi.com/1420-3049/28/3/1388/pdf
Reference49 articles.
1. Therapeutic Potential of Quinazoline Derivatives for Alzheimer’s Disease: A Comprehensive Review;Haghighijoo;Eur. J. Med. Chem.,2022
2. Alzheimer’s Disease Therapy: Present and Future Molecules;Kumar;Neuromethods,2018
3. Breijyeh, Z., and Karaman, R. (2020). Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules, 25.
4. Alzheimer’s Disease: An Update and Insights Into Pathophysiology;Abubakar;Front. Aging Neurosci.,2022
5. The Chemistry of Alzheimer’s Disease;Rauk;Chem. Soc. Rev.,2009
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Interactions of memantine and rivastigmine with graphene oxide nanocarrier and beta-amyloid protein using molecular docking and in-silico methods;Heliyon;2024-09
2. Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection;Neurochemistry International;2024-07
3. Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis;International Journal of Surgery;2024-03-19
4. QSAR application of natural therapeutics inhibitors against Alzheimer's disease through in-silico virtual-screening, docking-simulation, molecular dynamics, and pharmacokinetic prediction analysis;Intelligent Pharmacy;2023-12
5. 2‐Oxoquinoline‐based‐thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors;Archiv der Pharmazie;2023-09-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3